U.S. TikTok, Tencent WeChat bans could be threat to Nasdaq rally, Barron's says » 10:3508/0808/08/20
TCEHY, MSFT, ATVI, UBSFY, SNAP, SPOT, TSLA
This past week, the White…
This past week, the White House opened a new front in the cold war fight with China by issuing executive orders banning U.S. companies from working with TikTok and Tencent's (TECHY) WeChat, Connor Smith writes in this week's edition of Barron's. The TikTok news wasn't a surprise as the Trump administration has target it for weeks, leading Microsoft (MSFT) to consider a purchase of TikTok's U.S. operations, but the Tencent news stunned investors, the author notes, adding that the news rippled through the videogame industry, where Tencent is a dominant force. The company owns Riot Games, publisher of League of Legends, and holds a 40% stake in Epic Games, publisher of Fortnite, and also has stakes in companies like Activision Blizzard (AVTI), Ubisoft (UBSFY), Snap (SNAP), Spotify (SPOT) and Tesla (TSLA). Reference Link
Livongo Health downgraded to Hold after Teledoc deal at Benchmark » 07:2308/0708/07/20
As previously reported,…
As previously reported, Benchmark analyst Bill Sutherland downgraded Livongo Health (LVGO) to Hold from Buy following the company's announcement of an agreement to be acquired by Teledoc (TDOC). He sees no substantial hurdles to the deal closing and has "trouble imagining a higher bid," Sutherland said.
Livongo Health downgraded to Hold from Buy at Benchmark » 06:5908/0708/07/20
Benchmark analyst Bill…
Benchmark analyst Bill Sutherland downgraded Livongo Health to Hold from Buy.
BioLife Solutions reports Q2 non-GAAP EPS (1c), consensus (3c) » 16:3908/0608/06/20
Reports Q2 revenue $9.9M,…
Reports Q2 revenue $9.9M, consensus $9.57M. Mike Rice, CEO, commented, "We continued to advance the business during the second quarter, achieving record revenue and further adoption of our media, thaw, evo cold chain and freezer platforms. In the first half of 2020, we gained 88 new customers across the product portfolio. Significant institutional investor interest resulted in our completion of an oversubscribed public stock offering just after the close of the quarter. BioLife is very well positioned for both organic and additional acquisition driven growth."
Airlines rise as U.S. lifts global Level 4 health advisory for travel » 14:1708/0608/06/20
ALK, LUV, DAL, JBLU, UAL, SAVE, AAL
On August 6, in close…
On August 6, in close coordination with the U.S. Centers for Disease Control and Prevention, the Department of State lifted the Global Level 4 Health Advisory, the Department announced. "The Global Advisory, initially put in place on March 19, 2020, advised U.S. citizens to avoid all international travel due to the global impact of COVID-19. With health and safety conditions improving in some countries and potentially deteriorating in others, the Department is returning to our previous system of country-specific levels of travel advice (with Levels from 1-4 depending on country-specific conditions), in order to give travelers detailed and actionable information to make informed travel decisions. This will also provide U.S. citizens more detailed information about the current status in each country. We continue to recommend U.S. citizens exercise caution when traveling abroad due to the unpredictable nature of the pandemic." Publicly traded airlines include Alaska Air (ALK), American Airlines (AAL), Delta Air Lines (DAL), JetBlue (JBLU), Southwest (LUV), Spirit Airlines (SAVE) and United Airlines (UAL).
Greenlight Capital's Einhorn: Tesla short detracted from performance in Q2 09:1208/0608/06/20
Nu Skin price target raised to $57 from $50 at Jefferies » 08:3808/0608/06/20
Jefferies analyst Stephanie Wissink raised the firm's price target on Nu Skin to $57 from $50 and keeps a Buy rating on the shares. The company's Q2 sales were slightly ahead of the early-July pre-announcement, but the "standout measure" was total customers reaching an all-time high, Wissink tells investors. She sees Nu Skin's reduced dependence on China and robust growth in North America and EMEA as "especially encouraging," the analyst added.
Nu Skin price target raised to $61 from $54 at DA Davidson » 08:0108/0608/06/20
DA Davidson analyst Linda…
DA Davidson analyst Linda Bolton Weiser raised the firm's price target on Nu Skin to $61 from $54 and keeps a Buy rating on the shares after its Q2 results and Q3 guidance. The company's sales growth is improving thanks to its socially enabled business model, the management's investments in technology, as well as Nu Skin's balanced product portfolio, the analyst tells investors in her research note.
Nu Skin price target raised to $49 from $35 at Deutsche Bank » 07:4908/0608/06/20
Deutsche Bank analyst…
Deutsche Bank analyst Faiza Alwy raised the firm's price target on Nu Skin Enterprises to $49 from $35 and keeps a Hold rating on the shares. The analyst was surprised by the Q2 revenue upside on the strength of social selling in the U.S. and Europe amidst lockdown conditions.
Teladoc price target lowered to $225 from $238 at Deutsche Bank » 07:4108/0608/06/20
Deutsche Bank analyst…
Deutsche Bank analyst George Hill lowered the firm's price target on Teladoc Health (TDOC) to $225 from $238 and keeps a Buy rating on the shares after the company announced a merger with Livongo Health (LVGO). The analyst views Livongo as a "compelling asset and a strong strategic fit" but admits the multiple paid is "eye watering."